TGFB1 and neoplasm: The TGFβ-TGFβR and EGFR-NRG1 binding between receptor and ligand was obvious in CAF/CT26 subgroups, revealing that the CAFs and CT26 tumor cells cross talk through TGF pathway and affect the expression of EGFR to transform the tumor cells.